Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer

Mirko Marabese, Sergio Marchini, Eleonora Marrazzo, Pietro Mariani, Dario Cattaneo, Roldano Fossati, Anna Compagnoni, Mauro Signorelli, Ute M. Moll, A. Maria Codegoni, Massimo Broggini

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The p53 gene has been investigated for its role in epithelial ovarian cancer but data collected until now are contradictory. The evidence that p53 belongs with p63 and p73 to a family of transcription factors re-opened interest in this gene family. Here, we used quantitative real time RT-PCR to determine expression levels of TAp53, TAp73 and their N-terminal splice variants in a cohort of 169 ovarian cancer patients with stage I and stage III disease. The TAp73 levels in stage III biopsies differed by 100-fold depending on the p53 status and overall survival appears to be significantly related to ΔNp73 expression. Kaplan-Meyer analyses did not suggest a correlation between overall survival and levels of TAp73, ΔNp73 or the ΔNp73/TAp73 ratio. In conclusion, these data suggest that at least in our patient cohort p53 and p73 expression levels are not correlated to malignant progression of ovarian cancer. They might, however, play a role in tumour initiation.

Original languageEnglish
Pages (from-to)131-141
Number of pages11
JournalEuropean Journal of Cancer
Volume44
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Ovarian Neoplasms
Protein Isoforms
Survival
p53 Genes
Real-Time Polymerase Chain Reaction
Transcription Factors
Biopsy
Genes
Neoplasms
Ovarian epithelial cancer

Keywords

  • Ovarian cancer
  • p53
  • p73
  • Splice variants

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer. / Marabese, Mirko; Marchini, Sergio; Marrazzo, Eleonora; Mariani, Pietro; Cattaneo, Dario; Fossati, Roldano; Compagnoni, Anna; Signorelli, Mauro; Moll, Ute M.; Codegoni, A. Maria; Broggini, Massimo.

In: European Journal of Cancer, Vol. 44, No. 1, 01.2008, p. 131-141.

Research output: Contribution to journalArticle

Marabese, Mirko ; Marchini, Sergio ; Marrazzo, Eleonora ; Mariani, Pietro ; Cattaneo, Dario ; Fossati, Roldano ; Compagnoni, Anna ; Signorelli, Mauro ; Moll, Ute M. ; Codegoni, A. Maria ; Broggini, Massimo. / Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer. In: European Journal of Cancer. 2008 ; Vol. 44, No. 1. pp. 131-141.
@article{05998bf24b5840bab07f4bdded34f956,
title = "Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer",
abstract = "The p53 gene has been investigated for its role in epithelial ovarian cancer but data collected until now are contradictory. The evidence that p53 belongs with p63 and p73 to a family of transcription factors re-opened interest in this gene family. Here, we used quantitative real time RT-PCR to determine expression levels of TAp53, TAp73 and their N-terminal splice variants in a cohort of 169 ovarian cancer patients with stage I and stage III disease. The TAp73 levels in stage III biopsies differed by 100-fold depending on the p53 status and overall survival appears to be significantly related to ΔNp73 expression. Kaplan-Meyer analyses did not suggest a correlation between overall survival and levels of TAp73, ΔNp73 or the ΔNp73/TAp73 ratio. In conclusion, these data suggest that at least in our patient cohort p53 and p73 expression levels are not correlated to malignant progression of ovarian cancer. They might, however, play a role in tumour initiation.",
keywords = "Ovarian cancer, p53, p73, Splice variants",
author = "Mirko Marabese and Sergio Marchini and Eleonora Marrazzo and Pietro Mariani and Dario Cattaneo and Roldano Fossati and Anna Compagnoni and Mauro Signorelli and Moll, {Ute M.} and Codegoni, {A. Maria} and Massimo Broggini",
year = "2008",
month = "1",
doi = "10.1016/j.ejca.2007.10.011",
language = "English",
volume = "44",
pages = "131--141",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "1",

}

TY - JOUR

T1 - Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer

AU - Marabese, Mirko

AU - Marchini, Sergio

AU - Marrazzo, Eleonora

AU - Mariani, Pietro

AU - Cattaneo, Dario

AU - Fossati, Roldano

AU - Compagnoni, Anna

AU - Signorelli, Mauro

AU - Moll, Ute M.

AU - Codegoni, A. Maria

AU - Broggini, Massimo

PY - 2008/1

Y1 - 2008/1

N2 - The p53 gene has been investigated for its role in epithelial ovarian cancer but data collected until now are contradictory. The evidence that p53 belongs with p63 and p73 to a family of transcription factors re-opened interest in this gene family. Here, we used quantitative real time RT-PCR to determine expression levels of TAp53, TAp73 and their N-terminal splice variants in a cohort of 169 ovarian cancer patients with stage I and stage III disease. The TAp73 levels in stage III biopsies differed by 100-fold depending on the p53 status and overall survival appears to be significantly related to ΔNp73 expression. Kaplan-Meyer analyses did not suggest a correlation between overall survival and levels of TAp73, ΔNp73 or the ΔNp73/TAp73 ratio. In conclusion, these data suggest that at least in our patient cohort p53 and p73 expression levels are not correlated to malignant progression of ovarian cancer. They might, however, play a role in tumour initiation.

AB - The p53 gene has been investigated for its role in epithelial ovarian cancer but data collected until now are contradictory. The evidence that p53 belongs with p63 and p73 to a family of transcription factors re-opened interest in this gene family. Here, we used quantitative real time RT-PCR to determine expression levels of TAp53, TAp73 and their N-terminal splice variants in a cohort of 169 ovarian cancer patients with stage I and stage III disease. The TAp73 levels in stage III biopsies differed by 100-fold depending on the p53 status and overall survival appears to be significantly related to ΔNp73 expression. Kaplan-Meyer analyses did not suggest a correlation between overall survival and levels of TAp73, ΔNp73 or the ΔNp73/TAp73 ratio. In conclusion, these data suggest that at least in our patient cohort p53 and p73 expression levels are not correlated to malignant progression of ovarian cancer. They might, however, play a role in tumour initiation.

KW - Ovarian cancer

KW - p53

KW - p73

KW - Splice variants

UR - http://www.scopus.com/inward/record.url?scp=37149012746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37149012746&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2007.10.011

DO - 10.1016/j.ejca.2007.10.011

M3 - Article

VL - 44

SP - 131

EP - 141

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 1

ER -